Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 High-Yielding U.S. Pharmaceutical Companies to Consider

TheMotleyFool

0 0

3 High-Yielding U.S. Pharmaceutical Companies to ConsiderPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

The stock market has been bullish for years now, and most companies are richly valued as a result. Meanwhile, dividend yields remain low -- right now, the SPDR S&P 500 ETF (NYSEMKT: SPY) offers just 1.7%.

What's an investor seeking returns to do?

One attractive option is the pharmaceutical sector, where some large-cap companies are maintaining the winning trifecta of a stable dividend yield, ongoing earnings growth, and attractive valuation. For these three businesses in particular, company-specific events including acquisitions and new drugs make for particularly enticing prospects. Let's take a look at AbbVie (NYSE: ABBV), Bristol-Myers Squibb (NYSE: BMY), and Gilead Sciences (NASDAQ: GILD).

Source Fool.com

Like: 0

BMY

Share